These popular dry shampoos are being recalled due to potential cancer-causing ingredient

Because so many of us rely on the magic of dry shampoo as part of our daily routine, it’s important to know that Unilever is putting forth a dry shampoo recall for many of its popular products. The concern is that these dry shampoos may contain elevated levels of benzene—a cancer-causing carcinogen—in them.

This recall is the latest of half a dozen so far this year over benzene contamination, with the cancer-causing chemical showing up in popular deodorants, hand sanitizers and sunscreens. An internal investigation identified the benzene issue, and Unilever worked with its propellant suppliers to address the issue.

Related: Dozens of dry shampoos have been recalled—here’s what you need to know

“Benzene is classified as a human carcinogen,” the FDA says in a statement. “Exposure to benzene can occur by inhalation, orally, and through the skin and it can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life threatening. Benzene is ubiquitous in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources.”

The latest recall includes dry shampoo aerosol products made before October 2021 from brands Dove, Nexxus, Suave, TIGI (Rockaholic and Bed Head), and TRESemmé, the company said in a notice published on Friday by the U.S. Food and Drug Administration.

Related: Johnson & Johnson recalls popular Neutrogena, Aveeno sunscreens

A complete list of affected products and UPC codes can be found here.

What to do if you’re affected by the dry shampoo recall 2022

Consumers who have purchased any of the affected products should stop using the affected aerosol dry shampoo products and visit UnileverRecall.com for instructions on how to receive reimbursement for eligible products. If consumers have further questions, they may also contact Unilever U.S. by calling (877) 270-7412, Monday through Friday, 8:30 a.m. to 9 p.m. EST.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178